Advancing Gene Editing and mRNA Vaccine Technologies in Brazil

March 9, 2022 | 11:00 a.m.-2:40 p.m. (CT)


Agenda

Times are listed in BST. (View this event in your time zone)

Introduction

2-2:10 p.m.

Sang W. Han, PhD, Federal University of Sao Paulo (UNIFESP) 

mRNA Vaccines

2:10-3:10 p.m.  

  • Clinical Experience and Production of mRNA Vaccines
    Patrícia Cristina da Costa Neves, PhD, Biomanguinhos/FIOCRUZ 

  • Developing mRNA Vaccine Technology
    Margaret Liu, MD, ProTherImmune 

  • Panel discussion moderated by Martín Bonamino, PhD, National institute of Cancer (INCA) 

3:10-3:20 p.m.: Break 

In Vivo Gene Editing and Disease Modeling  

3:20-4:20 p.m. 

  • Disease Modeling and Gene Editing in Human iPSC-Derived Cardiomyocytes
    Adriana Bastos Carvalho, PhD, Federal University of Rio de Janeiro (UFRJ) 

  • Liron Walsh, MD, Intellia Therapeutics 

  • Panel discussion moderated by Fernanda Ferreira Cruz, PhD, Federal University of Rio de Janeiro (UFRJ) 

4:20-4:30 p.m.: Break 

Ex Vivo Gene Editing

4:30-5:30 p.m. 

  • Ricardo Weinlich, PhD, Einstein Hospital 

  • Matthew Porteus, MD, PhD, Stanford University School of Medicine

  • Panel discussion moderated by Guilherme Baldo, PhD, Federal University of Rio Grande do Sul (UFRGS)

Closing Remarks

5:30-5:40 p.m.

2022

ASGCT Policy Summit

Watch On Demand Through Oct. 27

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.